).
7. Muzio, M., et al., Science 278, 1612-1615 (1997).
8. Cao, Z., et al., Science 383, 443-446 (1996).
9. Muzio, M., et al., J. Exp. Med. 187, 2097-2101
(1998).
10. Song, H. Y., et al., Proc. Natl
).
7. Muzio, M., et al., Science 278, 1612-1615 (1997).
8. Cao, Z., et al., Science 383, 443-446 (1996).
9. Muzio, M., et al., J. Exp. Med. 187, 2097-2101
(1998).
10. Song, H. Y., et al., Proc. Natl
al., J. Virol., 77(7), 4396-4400
(2003).
8. Arnold, J.N. et al., J. Biol. Chem., 281(11), 6955-
6963 (2006).
9. Jarousse, N. et al., J. Immunol., 187(11), 5540-
5547 (2011).
10. Passmore, C.
in Methods of Biochemical Analysis,
20, 43-86.
8. Bechtol, K.B. et al., American Biotechnology Lab,
p. 8, December 1994.
9. Anal. Biochem., 65, 225 (1975).
10. Severini, A. and Morgan, A.R., Anal.
in Methods of Biochemical Analysis,
20, 43-86.
8. Bechtol, K.B. et al., American Biotechnology Lab,
p. 8, December 1994.
9. Anal. Biochem., 65, 225 (1975).
10. Severini, A. and Morgan, A.R., Anal.
al., J. Virol., 77(7), 4396-4400
(2003).
8. Arnold, J.N. et al., J. Biol. Chem., 281(11),
6955-6963 (2006).
9. Jarousse, N. et al., J. Immunol., 187(11),
5540-5547 (2011).
10. Passmore
Hardie, W.D., et al. 1993. Prostaglandins 45, 47.
24. Kaye, D., et al. 1997. Eur. J. Pharmacol. 340, 187.
continued on next page
hydrolyzes glycerophospholipids at the sn-2 position yield-
ing
and diabetic rats. Diabetes 12:115-126, 1963.
2. Thorell, J.I. Scand. J. Clin. Lab. Invest. 31:187, 1973.
3. Feldman, H. and Rodbard, D. “Mathematical Theory of Radioimmunoassay”, in: W.D. Odell
Required for Normal Splenic
Microarchitecture and B Cell-mediated Immune Responses. J. Exp. Med.
187:185-196.
Carmeliet, P., Y. Dor, J-M. Herbert, D. Fukumura, K. Brusselmans, M.
Dewerchin, M. Neeman
Required for Normal Splenic Microarchitecture and B Cell-
mediated Immune Responses. J. Exp. Med. 187:185-196.
Carmeliet, P., Y. Dor, J-M. Herbert, D. Fukumura, K. Brusselmans, M.
Dewerchin, M.
Required for Normal Splenic
Microarchitecture and B Cell-mediated Immune Responses. J. Exp. Med.
187:185-196.
Carmeliet, P., Y. Dor, J-M. Herbert, D. Fukumura, K. Brusselmans, M.
Dewerchin, M.
Yokoyama, S., and
Wilson, I. A. (2001) Science 294,
89–92.
4. Service, R. F. (2001) Science 292,
187–188.
5. Brush, M. (2002) The Scientist 16,
38–41.
6. Knaust, R. K. C. and Nordlund, P.
(2001)
Releasing Factor C5348 1392 CRH P NP_000747.1 y y y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP
Releasing Factor C5348 1392 CRH P NP_000747.1 y y y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP
Releasing Factor C5348 1392 CRH P NP_000747.1 y y y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP